Reply
Reply to letter by Nardelli and Schell commenting on the pathogenesis of lyme arthritis
Mario M. D'Elios MD,
Gaia Codolo MSc,
Marina de Bernard PhD,
Mario M. D'Elios MD
University of Florence, and Azienda Ospedaliera Universitaria Careggi, Florence, Italy
Search for more papers by this authorGaia Codolo MSc
University of Padua, and Venetian Institute of Molecular Medicine, Padua, Italy
Search for more papers by this authorMarina de Bernard PhD
University of Padua, and Venetian Institute of Molecular Medicine, Padua, Italy
Search for more papers by this authorMario M. D'Elios MD,
Gaia Codolo MSc,
Marina de Bernard PhD,
Mario M. D'Elios MD
University of Florence, and Azienda Ospedaliera Universitaria Careggi, Florence, Italy
Search for more papers by this authorGaia Codolo MSc
University of Padua, and Venetian Institute of Molecular Medicine, Padua, Italy
Search for more papers by this authorMarina de Bernard PhD
University of Padua, and Venetian Institute of Molecular Medicine, Padua, Italy
Search for more papers by this authorNo abstract is available for this article.
References
- 1
Nardelli DT,
Schell RF.
Expanded role for interleukin-17 in Lyme arthritis: comment on the article by Codolo et al [letter].
Arthritis Rheum
2009;
60:
1202.
10.1002/art.24415 Google Scholar
- 2 Codolo G, Amedei A, Steere AC, Papinutto E, Cappon A, Polenghi A, et al. Borrelia burgdorferi NapA–driven Th17 cell inflammation in Lyme arthritis. Arthritis Rheum 2008; 58: 3609–17.
- 3 Yssel H, Shanafelt MC, Soderberg C, Schneider PV, Anzola J, Peltz G. Borrelia burgdorferi activates a T helper type 1-like T cell subset in Lyme arthritis. J Exp Med 1991; 174: 593–601.
- 4 Gross DM, Steere AC, Huber BT. T helper 1 response is dominant and localized to the synovial fluid in patients with Lyme arthritis. J Immunol 1998; 1602: 1022–8.
- 5 Brown CR, Reiner SL. Experimental Lyme arthritis in the absence of interleukin-4 or γ interferon. Infect Immun 1999; 67: 3329–33.
- 6 Christopherson JA, Munson EL, England DM, Croke CL, Remington MC, Molitor ML, et al. Destructive arthritis in vaccinated interferon γ-deficient mice challenged with Borrelia burgdorferi: modulation by tumor necrosis factor α. Clin Diagn Lab Immunol 2003; 10: 44–52.
- 7 Burchill MA, Nardelli DT, England DM, DeCoster DJ, Christopherson JA, Callister SM, et al. Inhibition of interleukin-17 prevents the development of arthritis in vaccinated mice challenged with Borrelia burgdorferi. Infect Immun 2003; 71: 3437–42.
- 8 Infante-Duarte C, Horton HF, Byrne MC, Kamradt T. Microbial lipopeptides induce the production of IL-17 in Th cells. J Immunol 2000; 165: 6107–15.
- 9 Nardelli DT, Luk KH, Kotloski NJ, Warner TF, Torrealba JR, Callister SM, et al. Role of IL-17, transforming growth factor-β, and IL-6 in the development of arthritis and production of anti-outer surface protein A borreliacidal antibodies in Borrelia-vaccinated and -challenged mice. FEMS Immunol Med Microbiol 2008; 53: 265–74.
- 10 Nardelli DT, Cloute JP, Luk KH, Torrealba J, Warner TF, Callister SM, et al. CD4+CD25+ T cells prevent arthritis associated with Borrelia vaccination and infection. Clin Diagn Lab Immunol 2005; 12: 786–92.
- 11 Dong C. TH17 cells in development: an updated view of their molecular identity and genetic programming. Nat Rev Immunol 2008; 8: 337–48.
